Orchestration of Autophagy and Senescence: Kinases Take the Center Stage.
Key claim: Protein kinases, especially mTORC1 and MAPKs, orchestrate the bidirectional interplay between autophagy and cellular senescence and are candidate drug targets for aging and cancer.
Abstract
Autophagy was originally identified as a survival mechanism to allow cells to survive under nutrient-deprived or stressful conditions whereas cellular senescence was considered a tumor-suppressive mechanism. Both processes can be induced by similar stimuli and can influence each other. There have been continued debates about whether they are causally linked, whether autophagy promotes or prevents senescence or if they are independent of each other. Protein kinases play integral roles in cell fate decision and have a major influence on both autophagy and senescence. While mechanistic target of rapamycin complex 1 is considered the master regulator of autophagy, it also influences senescence. Mitogen-activated protein kinases originally associated with senescence can regulate autophagy. While there have been numerous review articles on the interplay between autophagy and senescence, a comprehensive review on how various kinases participate in this interplay is lacking. The purpose of this review is to learn lessons from some old and recent studies to understand how kinases contribute to this changing field. Since both autophagy and senescence can have beneficial and detrimental effects and kinases are important drug targets, insights regarding how kinases orchestrate these two processes should help develop therapeutic strategies to treat diseases, such as aging and cancer.
Why this matters
Protein kinases, especially mTORC1 and MAPKs, orchestrate the bidirectional interplay between autophagy and cellular senescence and are candidate drug targets for aging and cancer.